<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Farcaş</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Măhălean</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Bulik</surname>
    <given-names>NB</given-names>
   </name>
   <name>
    <surname>Leucuta</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Mogoșan</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <article-title>New safety signals assessed by the Pharmacovigilance Risk Assessment Committee at EU level in 2014–2017</article-title>
  <source>Expert Rev Clin Pharmacol.</source>
  <year>2018</year>
  <volume>11</volume>
  <issue>10</issue>
  <fpage>1045</fpage>
  <lpage>1051</lpage>
  <pub-id pub-id-type="doi">10.1080/17512433.2018.1526676</pub-id>
  <?supplied-pmid 30269618?>
  <pub-id pub-id-type="pmid">30269618</pub-id>
 </element-citation>
</ref>
